Tech Company Inital Public Offerings
Pandion Therapeutics IPO
Pandion Therapeutics was acquired by . Shares were listed on 7/16/2020.
Transaction Overview
Company Name
Announced On
7/16/2020
Transaction Type
IPO
Amount
$135,000,000
Proceeds Purpose
Per the firm's most recent regulatory filing, it plans to use the net proceeds as follows: approximately $55.0 million to advance the development of PT101, including our Phase 1a clinical trial in healthy volunteers and our planned Phase 1b/2a clinical trial for the treatment of patients with moderate-to-severe ulcerative colitis; approximately $38.0 million to continue research and development of PT627 and PT001, including preclinical research, IND-enabling studies and a Phase 1a clinical trial for each of PT627 and PT001; approximately $23.5 million to continue research and development of PT002 and our TALON discovery programs; and the remainder for working capital and other general corporate purposes.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
610 Main St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rahul Kakkar
Chief Operating Officer
Ed Freedman
Chief Scientific Officer
Jo Viney
VP - Bus. Development
Vikas Goyal
VP - Engineering
Hussam Shaheen
Browse more venture capital transactions:
Prev: 7/16/2020: Lithic venture capital transaction
Next: 7/16/2020: Noteworth venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs